Search for " " - 2/142

Results for “ ”

Entry	Author	Date	Location
After First Look at House Drug Plan, Stocks Rise Slightly	Alex Lash	09/10/19	National
Herceptin Inventors, Immunology Pioneers Take Home 2019 Lasker Awards	Ben Fidler	09/10/19	National
At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More	Ben Fidler	09/09/19	National
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone	Frank Vinluan	09/06/19	National
With FDA’s Eye on JAK Drugs, Concert Moves One Ahead For Hair Loss	Ben Fidler	09/03/19	Boston
Robocalls Crowd Out Real Business Calls. This Startup Has an Answer.	David Holley	08/30/19	Seattle
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More	Alex Lash	08/30/19	National
$5.8B for Nothing: AbbVie Shelves Stemcentrx Drug After Latest Flop	Ben Fidler	08/29/19	Detroit Ann Arbor
ThoughtSpot Nabs $248M for Accessible Analytics, Nears $2B Valuation	Bernadette Tansey	08/28/19	San Francisco
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)	Alex Lash	08/26/19	National
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More	Frank Vinluan	08/23/19	National
Ford’s Autonomic Connects EV Maker Ayro to Its Mobility Cloud	Bernadette Tansey	08/21/19	San Francisco
Elanco’s $7.6B Deal With Bayer Bolsters Pets, Farm Animals Footprint	Frank Vinluan	08/20/19	Indiana
Bio Roundup: Zolgensma Fallout, Duchenne Redux, Ebola Boost & More	Alex Lash	08/16/19	National
Will Porsche Fans Ever Live in a Driverless World? Porsche Says No.	Bernadette Tansey	08/16/19	San Francisco
Four New Drugs Are Around the Corner. Here’s What You Need to Know.	Ben Fidler	08/15/19	National
Mason Raises $25M to Help Software Firms Deploy, Manage Applications	Jeff Buchanan	08/14/19	Seattle
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More	Frank Vinluan	08/02/19	National
Ford, Retreating From Bold Timeline, Buys Quantum Signal for AV Tech	Bernadette Tansey	08/01/19	San Francisco
Amicus Offers First Look At Gene Therapy Work With Batten’s Data	Ben Fidler	08/01/19	New York
White House Floats Canadian Import Plan But Excludes Many Costly Drugs	Frank Vinluan	07/31/19	National
Mark Levin Named Xconomy’s 2019 Lifetime Achievement Award Winner in Boston	Angela Shah	07/31/19	National
Duchenne Advocates Start Casimir, Aiming to Capture Missing Data	Ben Fidler	07/26/19	Boston
Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More	Ben Fidler	07/26/19	National
No Co-Founder? Y Combinator Offers Matchmaking at Startup School	Bernadette Tansey	07/26/19	San Francisco
As Castle Bio Jumps on IPO Train, Industry Trends Suggest Slowdown	Frank Vinluan	07/25/19	National
Freenome Snags $160M to Boost Blood Test for Early Cancer Detection	Bernadette Tansey	07/24/19	San Francisco
With Regulator’s Nod, Bosch Plans Spread of Driverless Valet Parking	Bernadette Tansey	07/23/19	San Francisco
Could Facebook’s Crypto Break Financial System? Congress Airs Fears	Bernadette Tansey	07/19/19	San Francisco
Bio Roundup: Opioid Exposé, Gilead’s Gambit, Life Science IPOs & More	Frank Vinluan	07/19/19	National
Page 2 of 119	« previous page · next page »

Underwriters and Partners

Xpertise: Watch + Learn

Sponsored · Whitepaper
Time Savings That Speed up Science
Monitor spending and save meaningful dollars with life sciences-specific rewards
Brex

From Our Editors · Special Report
2019 Biopharma Outlook – Facing an Uncertain Future
Key indicators & expert insight from industry leaders
Xconomy

From Our Partners · Special Report
Robert Langer reveals secrets to early-stage biotech success
Advice for funding and future transformational opportunities